Article

Increased production of human granulocyte-macrophage colony stimulating factor (hGM-CSF) by the addition of stabilizing polymer in plant suspension cultures.

Basic Science Research Institute, Chonbuk National University, Dukjindong 664-14, Chonju, Chonbuk 561-756, South Korea.
Journal of Biotechnology (impact factor: 3.05). 08/2002; 96(3):205-11. pp.205-11
Source: PubMed

ABSTRACT Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a glycoprotein that stimulates the production of granulocytes, macrophages, and white blood cells. Secretion of human GM-CSF from cell suspension cultures of genetically modified tobacco has been facilitated using natural mammalian leader sequences. At the mid-exponential growth phase (day 4 after the initiation of cell suspension culture), GM-CSF was detected in the medium at a maximum concentration of 180 microg l(-1). However, the secreted GM-CSF was unstable in the medium, and rapidly degraded after day 5. In order to stabilize the secreted GM-CSF, three stabilizing polymers were tested, polyethylene glycol, polyvinylpyrrolidone and gelatin. Gelatin was the most effective in stabilizing the secreted GM-CSF. Following the addition of 5% (w/v) gelatin, the maximum GM-CSF concentration reached 783 microg l(-1), a 4.6-fold increase over control.

0 0
 · 
0 Bookmarks
 · 
29 Views
  • Source
    Article: Plant cell cultures for the production of recombinant proteins.
    [show abstract] [hide abstract]
    ABSTRACT: The use of whole plants for the synthesis of recombinant proteins has received a great deal of attention recently because of advantages in economy, scalability and safety compared with traditional microbial and mammalian production systems. However, production systems that use whole plants lack several of the intrinsic benefits of cultured cells, including the precise control over growth conditions, batch-to-batch product consistency, a high level of containment and the ability to produce recombinant proteins in compliance with good manufacturing practice. Plant cell cultures combine the merits of whole-plant systems with those of microbial and animal cell cultures, and already have an established track record for the production of valuable therapeutic secondary metabolites. Although no recombinant proteins have yet been produced commercially using plant cell cultures, there have been many proof-of-principle studies and several companies are investigating the commercial feasibility of such production systems.
    Nature Biotechnology 12/2004; 22(11):1415-22. · 23.27 Impact Factor
  • Source
    Article: Recombinant cytokines from plants.
    [show abstract] [hide abstract]
    ABSTRACT: Plant-based platforms have been successfully applied for the last two decades for the efficient production of pharmaceutical proteins. The number of commercialized products biomanufactured in plants is, however, rather discouraging. Cytokines are small glycosylated polypeptides used in the treatment of cancer, immune disorders and various other related diseases. Because the clinical use of cytokines is limited by high production costs they are good candidates for plant-made pharmaceuticals. Several research groups explored the possibilities of cost-effective production of animal cytokines in plant systems. This review summarizes recent advances in this field.
    International Journal of Molecular Sciences 01/2011; 12(6):3536-52. · 2.60 Impact Factor

Full-text

View
1 Download
Available from

Keywords

4.6-fold increase
 
cell suspension culture
 
cell suspension cultures
 
day 5
 
Gelatin
 
glycoprotein
 
GM-CSF
 
Granulocyte-macrophage colony-stimulating factor
 
human GM-CSF
 
initiation
 
maximum GM-CSF concentration
 
mid-exponential growth phase
 
natural mammalian leader sequences
 
polyethylene glycol
 
secreted GM-CSF
 
white blood cells